It is suggested that BV6, in combination with TRAIL and TNFα, inhibits the autophagy process, whereas TRAIL and TNFα treatment increases autophagy in MCF7 and MDA-MB-231 breast cancer cells. The gene discussed is TNFSF10; the disease is breast cancer.